• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Professional Introduction to 1H-Pyrazol-3-amine,4-propyl- (CAS No. 151521-41-4)

1H-Pyrazol-3-amine,4-propyl-, identified by its Chemical Abstracts Service (CAS) number 151521-41-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrazole class, a family of molecules known for their diverse biological activities and structural versatility. The presence of an amine group at the 3-position and a propyl substituent at the 4-position imparts unique chemical and pharmacological properties, making it a valuable scaffold for the development of novel therapeutic agents.

The structural framework of 1H-Pyrazol-3-amine,4-propyl- consists of a five-membered aromatic ring containing two nitrogen atoms. This core structure is highly adaptable, allowing for modifications that can fine-tune its biological activity. The amine functionality at the 3-position serves as a potential site for further derivatization, enabling the synthesis of more complex molecules with enhanced pharmacological profiles. Additionally, the propyl group at the 4-position contributes to the compound's lipophilicity, which can influence its absorption, distribution, metabolism, and excretion (ADME) properties.

In recent years, there has been growing interest in pyrazole derivatives due to their broad spectrum of biological activities. These compounds have been investigated for their potential in treating various diseases, including inflammation, cancer, and infectious disorders. The amine group in 1H-Pyrazol-3-amine,4-propyl- can form hydrogen bonds with biological targets, enhancing binding affinity and selectivity. This property makes it particularly useful in designing small-molecule inhibitors and agonists.

One of the most compelling aspects of 1H-Pyrazol-3-amine,4-propyl- is its role as a building block in drug discovery. Researchers have leveraged this compound to develop novel molecules with improved efficacy and reduced toxicity. For instance, studies have shown that pyrazole derivatives can modulate enzyme activity by inhibiting key pathways involved in disease progression. The propyl substituent enhances solubility and bioavailability, making it an attractive candidate for further development.

Recent advancements in computational chemistry have further accelerated the design and optimization of 1H-Pyrazol-3-amine,4-propyl- derivatives. Molecular docking simulations and virtual screening techniques have enabled scientists to predict binding interactions with high precision. These tools have been instrumental in identifying lead compounds that exhibit promising pharmacological activity. By integrating experimental data with computational models, researchers can refine their strategies for developing new therapeutic agents.

The synthesis of 1H-Pyrazol-3-amine,4-propyl- involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between hydrazines and α-haloketones or α-bromoaldehydes, followed by functional group transformations to introduce the propyl substituent. Advances in synthetic methodologies have made it possible to produce this compound efficiently on both laboratory and industrial scales.

From a medicinal chemistry perspective, 1H-Pyrazol-3-amine,4-propyl- represents an important example of how structural modifications can influence biological activity. The interplay between electronic effects, steric hindrance, and solubility properties plays a crucial role in determining a compound's efficacy as a drug candidate. By understanding these relationships, chemists can design molecules that are optimized for specific therapeutic applications.

The pharmacological potential of 1H-Pyrazol-3-amine,4-propyl- has been explored in several preclinical studies. These investigations have highlighted its ability to interact with various biological targets, including kinases, receptors, and enzymes. For example, derivatives of this compound have shown inhibitory effects on pathways relevant to cancer cell proliferation and survival. Such findings underscore its significance as a pharmacological tool for further exploration.

In conclusion,1H-Pyrazol-3-aminese,propyl- CAS No. 151521- 41- 4 is a structurally interesting heterocyclic compound with significant pharmaceutical potential. Its unique combination of functional groups makes it a versatile scaffold for drug discovery, offering opportunities for the development of novel therapeutic agents. As research continues to uncover new biological targets and synthetic strategies, compounds like 1H-Pyrazol- -amine,propyl- - will undoubtedly play a crucial role in advancing medical science.

• 43024-15-3(4-Ethyl-1H-pyrazol-3-amine)
• 151521-49-2(4-(propan-2-yl)-1H-pyrazol-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)